Functional studies using antibodies against orphanin FQ/nociceptin
- 授权形式:免费版
- 作者/开发商:
- 文件大小:82.11 Kb
- 软件语言:Neuroscience Research Institute, Beijing Medical University, Beijing, China
- 版本号:Jin-Hua Tian1, Ji-Sheng Ha
- 软件平台:Win2000/WinXP/Win2003
- 软件类别:Peptides 21 (2000) 1047–1050
- 下载次数:7
- 评论等级:★★★☆☆
- 更新时间:2008-06-10
内容简介:
Jin-Hua Tian1, Ji-Sheng Han*
Neuroscience Research Institute, Beijing Medical University, Beijing, China
Received 20 November 1999; accepted 20 March 2000
Abstract
Orphanin FQ/nociceptin (OFQ) is a recently discovered endogenous ligand for the novel opioid receptor-like receptor (ORL-1). There are numerous reports in the literature demonstrating paradoxical effects of exogenous OFQ on pain modulation. For example, OFQ produces a pronociceptive effect in the brain and an analgesic effect in the spinal cord. In order to better understand the physiological actions of OFQ, the present study focused on the pain-modulatory effect of endogenously released OFQ measured using antibody microinjection techniques. We found that electroacupuncture analgesia (EA) was increased by intracerebroventricular (i.c.v.) injection of an OFQ-antibody and decreased following intrathecal injection. Furthermore, i.c.v. OFQ-antibody partially reversed tolerance to both chronic morphine and chronic EA. These data suggest that endogenously released OFQ plays an important role in pain modulation, where pain sensitivity in the brain and spinal cord is increased and decreased, respectively. © 2000 Elsevier Science Inc. All rights reserved.
Keywords: Orphanin FQ; Nociceptin; Antibody; Pain; Tolerance
相关评论
相关下载